CD20 monoclonal antibodies

Rituxan Hycela 1,600 mg/26,800 Units injection for subcutaneous use Images

Generic Name: hyaluronidase/rituximab

This medication has been identified as Rituxan Hycela 1,600 mg/26,800 Units injection for subcutaneous use. It is supplied by Genentech, Inc.

Rituxan Hycela is used in the treatment of Follicular Lymphoma; Diffuse Large B-Cell Lymphoma; Chronic Lymphocytic Leukemia and belongs to the drug class CD20 monoclonal antibodies. Rituxan Hycela 1,600 mg/26,800 Units injection for subcutaneous use is not a controlled substance under the Controlled Substances Act (CSA).

Images

Rituxan hycela (Hyaluronidase and rituximab [ hye-al-ure-on-i-dase ])-medicine-1,600 mg/26,800 Units injection for subcutaneous use

Rituxan hycela
Generic Name: hyaluronidase and rituximab [ hye-al-ure-on-i-dase ]
Imprint: medicine
Strength: 1,600 mg/26,800 Units injection for subcutaneous use
Color: N/A
Size: N/A
Shape: N/A
Availability: Prescription only
Drug Class: CD20 monoclonal antibodies
Pregnancy Category: N/A
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 50242-0109
Inactive Ingredients:
Latest News
Related Drugs